A Randomized Clinical Trial of the Collaborative Assessment and Management of Suicidality Versus Enhanced Care as Usual for Suicidal Soldiers
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
- 主要终点
- Scale for Suicidal Ideation
研究概览
简要总结
This is a randomized controlled trial comparing the use of new clinical intervention (the "Collaborative Assessment and Management of Suicidality--CAMS") versus enhanced care as usual for suicidal Soldiers who are seen at outpatient mental health clinics at Ft. Stewart GA.
详细描述
This is a randomized controlled clinical trial of 148 suicidal active-duty US Army Soldiers. Participants were randomized to on-site providers who were trained in the Collaborative Assessment and Management of Suicidality (CAMS) vs. providers doing their own routine care--referred to as Enhanced Care as Usual (E-CAU) within an outpatient military treatment center. The CAMS Rating Scale (CRS) was used to reliably verify fidelity between treatment conditions and the adherence by CAMS providers to the model. Participants received informed consent to be randomly assigned to treatment arm and were ask to complete study assessments at baseline, 3 months, 6 months, and 12 months after the start of treatment. Recruitment is complete and all study assessments were completed as of March 2016. The study is in a second year of no cost extension; outcome data analyses and moderator analyses are currently underway to develop manuscripts for submission to peer-review scientific journals.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Active duty Army personnel at FSGA
- •Significant suicidal ideation
- •Soldier is appropriate under FSGA policies
- •Consent at baseline and follow up
- •Consent to randomization and being digitally recorded
排除标准
- •Significant psychosis, cognitive or physical impairment to not give consent
- •Judicially ordered treatments
结局指标
主要结局
Scale for Suicidal Ideation
时间窗: Baseline, post-treatment, 1, 3, 6, 12 months
Industry standard for self-report suicidal ideation
次要结局
- Overall symptom distress(Baseline, post treatment, 1, 3, 6, 12 months)
研究者
David A. Jobes, Ph.D.
Professor of Psychology
The Catholic University of America
